Lotus Pharmaceuticals Stock Price Prediction

LTUS Stock  USD 0.01  0.0007  11.67%   
At this time, The relative strength index (RSI) of Lotus Pharmaceuticals' share price is at 57. This indicates that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Lotus Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
The successful prediction of Lotus Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Lotus Pharmaceuticals and does not consider all of the tangible or intangible factors available from Lotus Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Lotus Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Lotus Pharmaceuticals hype-based prediction, you can estimate the value of Lotus Pharmaceuticals from the perspective of Lotus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lotus Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Lotus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lotus Pharmaceuticals after-hype prediction price

    
  USD 0.0056  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Lotus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lotus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.00050.27
Details

Lotus Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Lotus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lotus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Lotus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Lotus Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Lotus Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lotus Pharmaceuticals' historical news coverage. Lotus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 50.27, respectively. We have considered Lotus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.01
0.01
After-hype Price
50.27
Upside
Lotus Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Lotus Pharmaceuticals is based on 3 months time horizon.

Lotus Pharmaceuticals Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Lotus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lotus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lotus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  16.67 
110.13
 0.00  
  0.49 
0 Events / Month
3 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.01
0.01
5.66 
0.00  
Notes

Lotus Pharmaceuticals Hype Timeline

Lotus Pharmaceuticals is now traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.49. Lotus is anticipated to increase in value after the next headline, with the price projected to jump to 0.0056 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is estimated to be 5.66%, whereas the daily expected return is now at 16.67%. The volatility of related hype on Lotus Pharmaceuticals is about 374910.64%, with the expected price after the next announcement by competition of 0.50. Lotus Pharmaceuticals currently holds about 158.91 K in cash with 26.78 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next anticipated press release will be uncertain.
Check out Lotus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Lotus Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Lotus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Lotus Pharmaceuticals' future price movements. Getting to know how Lotus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lotus Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CNCTChina Teletech Holding 0.00 0 per month 14.37  0.13  75.00 (42.86) 1,066 
AGGIAllied Energy 0.00 0 per month 7.26  0.11  27.52 (18.80) 150.04 
LOCCLive Oak Crestview(0.04)5 per month 0.00 (0.03) 0.30 (0.19) 1.57 
TRTLTortoiseEcofin Acquisition III(0.04)8 per month 0.00 (0.01) 0.18 (0.18) 0.74 
LCWLearn CW Investment 0.01 4 per month 2.05  0  0.18 (0.37) 13.17 
TCOATrajectory Alpha Acquisition 0.00 3 per month 0.00 (0.09) 0.63 (0.72) 1.91 
GAQGeneration Asia I 0.00 0 per month 0.00  0.20  0.53  0.00  1.16 
RJACJackson Acquisition Co 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ALSAAlpha Star Acquisition 0.00 0 per month 0.00 (0.12) 0.83 (0.59) 18.01 
ACACAcri Capital Acquisition 0.54 2 per month 3.84  0.01  12.07 (10.16) 30.82 
MBSCM3 Brigade Acquisition 0.00 2 per month 0.00 (0.06) 0.10 (0.10) 0.77 
TMXNTrimax Corp 0.00 0 per month 10.10  0.1  40.00 (22.22) 103.08 
LICHLiveChain 0.00 0 per month 20.89  0.16  165.38 (62.32) 342.50 
TMLLThird Millennium Industries 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
AHFDActive Health Foods 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ALPAAlpha Healthcare Acquisition 0.00 9 per month 0.00 (0.05) 0.29 (1.11) 14.74 

Lotus Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Lotus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lotus using various technical indicators. When you analyze Lotus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lotus Pharmaceuticals Predictive Indicators

The successful prediction of Lotus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lotus Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lotus Pharmaceuticals based on analysis of Lotus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lotus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lotus Pharmaceuticals's related companies.

Story Coverage note for Lotus Pharmaceuticals

The number of cover stories for Lotus Pharmaceuticals depends on current market conditions and Lotus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lotus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lotus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Lotus Pharmaceuticals Short Properties

Lotus Pharmaceuticals' future price predictability will typically decrease when Lotus Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lotus Pharmaceuticals often depends not only on the future outlook of the potential Lotus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lotus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Short Long Term DebtM

Additional Tools for Lotus Pink Sheet Analysis

When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.